It has been previously reported that CGs such as bufalin, glucoevatromonoside, digitoxin, and ouabain induce cell cycle arrest at the G2/M phase by deregulating the expression of polo-like kinase 1 (Plk1) expression in cancer cells (27, 28). This evidence concerns the gene PLK1 and cancer.